Abstract: Mammalian hair growth is reduced by applying to the skin a dermatologically acceptable composition including a catechin compound.

Abstract: Composition for slowing down the loss of hair and for inducing and stimulating its growth, comprising a compound of formula: ##STR1## in which: R.sub.1 and R.sub.2 denote H or an alkyl and do not simultaneously denote H;R.sub.3 and R.sub.4 denote H, an alkyl or a heterocyclic ring with the nitrogen in position 6 and do not simultaneously denote H;X denotes H or a halogen;Y denotes O or OSO.sub.3 ;and their addition salts of physiologically acceptable acids.

Abstract: A stable sulfide containing composition is disclosed, including a process for preparation thereof and a method for using the composition to soften nails or to treat ingrown toenail.

Abstract: The invention provides a composition for treating seborrheic dermatitis on the scalp, a method for treating seborrheic dermatitis and a method for making the composition of the invention. The composition of the invention, which is not a shampoo and does not contain any soap or detergent for cleaning hair, is a unique scalp medicament blend of ingredients. The composition comprises from about 0.5 to about 2.5 weight percent, based upon the weight of the composition, hydrocortisone; from about 2.5 to about 7.5 weight percent elemental sulfur; and from about 90 to about 97 weight percent of an active vehicle comprising a generally neutral hydrocarbon jelly, such as petrolatum or petroleum jelly, and gelled aqueous carboxypolymethylene.

Abstract: The instant invention involves a method of treating and/or reversing androgenic alopecia and promoting hair growth, and methods of treating acne vulgaris, seborrhea, and female hirsutism, by administering to a patient in need of such treatment a 5.alpha.-reductase 2 inhibitor, such as finasteride, in a dosage amount under 5 mgs/day.

Abstract: The present invention relates to a cosmetic conditioning and detergent composition for the hair which is stable and comprises, in an aqueous medium:(A) a conditioner system comprising at least one C.sub.14 -C.sub.22 fatty alcohol and at least one cationic surfactant selected from quaternary ammonium salts, and, optionally, at least one cationic silicone, and(B) a washing base comprising at least one alkylpolyglycoside nonionic surfactant, and optionally at least one amphoteric or zwitterionic surfactant, and(C) a stabilizer system comprising at least one stearate selected from glycol monostearates and glycol distearates and at least one crosslinked polymer of methacryloyloxyethyltrimethylammonium chloride.Also disclosed is a method for the simultaneous care and washing of hair.

Abstract: Pharmaceutical preparations for controlling proliferation of ectodermally-derived tissues comprising the specific negative growth factor activin A or an agonist thereof, and their use in methods of treatment of proliferative conditions and wound repair.

Abstract: This invention relates to pharmaceutical compositions containing 5'-deoxy-5'-methylthioadenosine, S-adenosyl-methionine and their pharmaceutically acceptable salts able to reduce scalp seborrhea and its related furfuraceous desquamation and pruritus.

Abstract: A method for hair treatment is disclosed wherein a first treatment solution comprising tea tree oil is periodically applied to the scalp for at least 10 days. Then, a second treatment solution comprising chlorine dioxide is periodically applied to the scalp, immediately followed by application of an acidic solution having an acidity effective to release the oxygen in the chlorine dioxide solution, for at least 1 month. Finally, a third treatment solution comprising saw palmetto berry extract is periodically applied to the scalp for at least 1 month. Also disclosed is a hair treatment kit comprising a first treatment solution comprising tea tree oil, a second treatment solution comprising chlorine dioxide, an acidic solution having a pH effective to release the oxygen from said chlorine dioxide in said second treatment solution, and a third treatment solution comprising saw palmetto berry extract.

Abstract: Disclosed is a hair-growing (restoration) agent which comprises a carnitine compound represented by the formula (I): ##STR1## wherein R.sup.1 to R.sup.3 each represent an alkyl group having 1 to 6 carbon atoms; R.sup.4 represents an aliphatic acyl group having 3 to 31 carbon atoms which may be substituted; R.sup.5 represents an alkyl group having 3 to 31 carbon atoms which may be substituted, or an alkenyl group having 3 to 31 carbon atoms which may be substituted; and X.sup.- represents an anion of a pharmaceutically acceptable acid,as an active ingredient.

Abstract: A scalp and hair treatment method and composition wherein the composition comprises deionized water, a vasodilator (such as ethyl nicotinate and/or capsicum extract), a magnesium salt, and a hydrolyzed protein. The composition can be applied on a monthly or bi-monthly basis to the scalp and hair for about 30 minutes and rinsed away with water.

Abstract: Methods and compositions for affecting the growth of hair which comprise hair growth promoting amounts of peptides containing the Lys-Pro-Val sequence not preceded by a histidine, valine or derivative thereof, are provided.

Abstract: What is described herein is the reaction product of arginine and p-aminobenzoic acid (PABA), cosmetic and human and animal health compositions thereof, useful for treating wounds (small or large animals and humans), burns (small or large animals and humans), sunburn (in humans, dogs and sheep), non-specific specific vaginitis (large animals), dermatitis (small or large animals and humans), pyoderma (small and large animals), rhabditis dermatitis (dogs and cattle), eczema nasi (dogs), exudative epidermitis (swine), saddle sores (horses), proudflesh (horses), hutchburn (rabbits), dermal lesions (small or large animals and humans), udder edema (cattle, goats and sheep), abscesses (small or large animals and humans) and bovine mastitis.

Abstract: Pharmaceutical preparations are provided comprising antiandrogenically effective substances encapsulated in liposomes. These preparations are preferably used for topical treatment of androgen-dependent diseases.

Abstract: The invention relates to the use of Medicago saponins for the preparation of cosmetic or pharmaceutical compositions. The invention provides for the incorporation of 0.01% to 5% by weight of a saponin or a corresponding sapogenin, or a plant extract in which it is present, originating in particular from lucerne leaves or roots. The invention makes it possible to promote renewal of the epidermis, stimulate hair regrowth or delay hair loss, or else to combat the effects of ageing on the state of the skin and scalp, as is evident from the FIGURE.

Abstract: Novel pharmaceutically/cosmetically-active polyaromatic propynyl compounds have the structural formula (1): ##STR1## in which X is one of the radicals: ##STR2## and are useful for the treatment of a wide variety of disease states, whether human or veterinary, for example dermatological, rheumatic, respiratory, cardiovascular and ophthalmological disorders, as well as for the treatment of mammalian skin and hair conditions/disorders.

Abstract: Cosmetic and/or dermatological active compound combinations comprisinga) an active amount of biotin and/or biotin esters,b) an active amount of one or more .alpha.-hydroxycarboxylic acids of the formulaR'(R")(OH)C COOHand/or an active amount of one or more .alpha.-ketocarboxylic acids of the formulaR'C(O) COOHor their physiologically acceptable salts or esters wherein R' and R" represent H-; branched or unbranched C.sub.1-25 -alkyl- or C.sub.1-25 -alkyl-substituted by one or more carboxyl groups and/or hydroxyl groups and/or a aldehyde groups and/or oxo groups (keto groups); phenyl- or phenyl substituted by one or more carboxyl groups and/or hydroxyl groups and/or branched and/or unbranched C.sub.1-25 -alkyl groups; or wherein the .alpha.-carbon atom of the .alpha.

Abstract: The present invention relates to a composition for washing and antidandruff treatment of hair and the scalp, containing in an aqueous medium at least selenium sulphide, at least one nonionic surface-active agent of the polyglycerolated or alkylpolyglycoside type, and at least one suspending agent chosen from the anionic cellulose derivatives and the biopolysaccharides.

Abstract: A sprayable hair fixing composition having the following components or reaction products comprisinga) from about 0.5 to about 10 wt. % of a high molecule weight copolymer of polyvinylpyrrolidine and vinylacetate, the weight average molecular weight of said polymer being at least about 200,000,b) from about 0.5 to about 8 wt. % of at least about 80 wt. % neutralized copolymer of tertiary butylacrylate, ethyl acrylate and methacrylic acid, andc) a solvent system compatible with the combination of copolymer a and copolymer b, the wt. % of a and b in the range of about 1:4 to about 4:1.

Abstract: A processed product for hair and skin treatment, having binary and tertiary fluid phase levels prior to remixing and therapeutic use is disclosed. The invention discloses defined amounts of admixed components including an Iodine complex having tincture of iodine solution and povidone-iodine compound, a diluting fluid complex having a water and mineral oil constituent, and a cod liver oil component, which, after admixing, are ambiently exposed to a photon-light-energy component from sunlight or substantially equivalent artificial light to produce a processed product having at least binary product reaction fluid levels and containing a nucleophically iodinated cod liver oil compound.

Abstract: A method of inhibiting hirsutism or alopecia in women comprising administering to a female human in need of treatment an effective amount of a compound having the formula ##STR1## wherein R.sup.1 and R.sup.3 are independently hydrogen, --CH.sub.3, ##STR2## wherein Ar is optionally substituted phenyl; R.sup.2 is selected from the group consisting of pyrrolidine, hexamethyleneamino, and piperidino; or a pharmaceutically acceptable salt of solvate thereof.

Abstract: A non-toxic, environmentally safe and easily employable insecticide and insect repellant is achieved by providing an aqueous composition incorporating ethanolamine based compounds, either independently or in combination with the ethanolamine based compounds being selected from both simple compounds and conjugated compounds. In one preferred embodiment, a highly effective composition is attained for safe, effective, direct topical application to humans and animals by employing between about 10% and 70% by volume of the entire composition of the ethanolamine-based compound. In alternate preferred embodiments, the insecticide is formulated for application to plants, trees, crops, and other vegetation to provide a composition which effectively controls bothersome insects, while being completely safe and non-injurious to the plant, tree, or crop, as well as to the flowers or fruit thereof.

Abstract: The invention is directed to Dead Sea mud for restoration of hair growth and retardation of hair loss for those suffering from alopecia and a hair therapy method of topically applying to the scalp of a human or other mammal scalp an effective amount of the Dead Sea mud. Dramatic results in overall hair therapy have been obtained by those individuals that have practiced the present method for a relatively short period of time.

Abstract: A thickening mixture containing, in an aqueous medium, (a) a component (A) consisting of at least one guar gum or non-ionic cellulose having no hydrophobic group, with a viscosity in solution of over 15 cps at 15 wt % in water, as measured by DRAGE module 2 at 25.degree. C.; (b) a component (B) consisting of at least one cross-linked polymer selected from (i) acrylamide and ammonium acrylate copolymers; (ii) acrylamide and partially or totally neutralized 2-acrylamido 2-methylpropane sulphonic acid copolymers; (iii) acrylamide and methacryloyl oxyethyl trimethylammonium chloride copolymers; and (iv) methacryloyl oxyethyl trimethylammonium chloride homopolymers; wherein the weight ratio of crosslinked polymer active material to guar gum or cellulose is 0.2-10. A cosmetic or dermatological hair- or skin-care composition containing said mixture is also provided.

Abstract: Mammalian hair growth is reduced by applying to the skin a dermatologically acceptable composition including a catechin compound.

Abstract: A hair shampoo composition comprising a cleansing surfactant; a water-insoluble hair treating compound, like a hair conditioner or an antidandruff agent; a suspending agent comprising an amine including at least one long carbon chain and a suitable acid; and a suitable carrier, and a method of treating hair are disclosed. The shampoo compositions effectively suspend the water-insoluble hair-treating compound, effectively cleanse the hair and effectively deliver the water-insoluble hair-treating compound to the hair or scalp.

Abstract: A live hair and skin treating cosmetic formulation containing a mixture of biochemicals obtained by boiling in water a composition containing potato peelings and lantana leaves.

Abstract: A class of pseudoceramide having the formula shown in which: R1 is a hydrocarbon group; R2-R8 are each independently H or CH.sub.3 ; R9 and R10 are each independently H or hydrocarbon group of up to 24 C atoms; X1 and X2, are independently H or OH; Y1 and Y2 are H or OH, at least one of Y1 and Y2 being OH; wherein the C atom Z, with associated R9 and R10, can be absent; and the C atoms W, with associated R7 and Y2, can be absent, is disclosed. These find use in compositions, particularly cosmetic compositions, suitable for topical application to skin, hair or nails.

Abstract: A preparation for promoting hair growth is disclosed, which contains as an effective ingredient or ingredients one or more compounds selected from the group consisting of purine compounds, pyridylurea compounds, diphenylurea compounds, pyrimidine compounds, imidazole compounds, benzoylaminourea compounds and 4-substituted aminopyrrolo[2,3-d]pyrimidine compounds. This preparation exhibits an excellent effect of promoting hair growth or curing alopecia such as male alopecia or alopecia areata. Of the effective compounds, purine compounds and pyridyl compounds exhibit particularly remarkable effects.

Abstract: A method of reducing hair growth in a mammal includes applying, to an area of skin from which reduced hair growth is desired, a dermatologically acceptable composition containing a suppressor of the metabolic pathway for the conversion of glucose to acetyl-CoA.

Abstract: Dermatological/cosmetic compositions for reducing or decelerating human hair loss comprise an effective hair loss-reducing amount of combinatory immixture of (a) at least one antifungal agent and (b) at least one halogenated antibacterial agent other than a macrolide or pyranoside, characteristically formulated in a topically physiologically acceptable medium therefor.

Abstract: Sebhorrhoeic skin conditions in dogs are treated by the topical application of the combination of an anti-fungal drug and a topical antiseptic.

Abstract: 1. Combination intended to induce and to stimulate the growth of hair and to reduce its loss, characterized in that it comprises:a) a component (A) containing, in an anhydrous, physiologically acceptable medium, at least hydrocortisone, its salts or esters, andb) a component (B) containing, in en anhydrous, physiologically acceptable medium, at least one pyrimidine derivative corresponding to the formula: ##STR1## in which R.sub.1 denotes a group ##STR2## in which R.sub.3 and R.sub.4, independently of each other, denote hydrogen or an alkyl, alkenyl, alkylaryl or cycloalkyl group; R.sub.3 and R.sub.4 may also form a heterocyclic ring with the nitrogen atom to which they are linked, which is chosen from aziridinyl, azetidinyl, pyrrolidinyl, piperidyl, hexahydroazepinyl, heptamethyleneimine, actamethyleneimine, morphaline and 4-(lower)aklylpiperazidinyl groups, it being possible for the heterocyclic groups to be substituted on the carbon atoms by one to three lower alkyl, hydroxyl or alkoxy groups; the group R.

Abstract: This invention relates to the method for treating the form of alopecia commonly known as "male pattern baldness" which comprises regular topical application to the affected areas of the human scalp of a composition containing as at least one of its active ingredients of Formula I. It also encompasses the aforesaid compound itself for use as a therapeutic agent to arrest and reverse male pattern alopecia.

Abstract: The invention provides a composition for the treatment for the hair, scalp and skin to improve condition and to assist in hair regrowth which comprises a pharmaceutically acceptable oxalate of a group Ia or Ia or ammonium oxalate metal disposed in a pharmaceutically acceptable carrier of diluent therefor. Preferably, the group IIa metal is calcium and the pharmaceutically acceptable carrier or diluent is an ointment.

Abstract: Deacylated glycerophospholipids, such as L-.alpha.-glycerylphosphorylcholine, L-.alpha.-glycerylphosphorylethanolamine, L-.alpha.-glycerylphosphorylserine, L-.alpha.-glycerylphosphoryl-D-myo-inositol are effective for topical use and may be incorporated into cosmetic or pharmaceutical compositions.

Abstract: The present invention provides a hair grower which prevents loss of hair, promoted hair development and cures alopecia, comprising as an active ingredient one or more of the following compounds: allantoin, derivatives thereof, compounds thereof and compounds of allantoin derivatives and optionally further comprising as an active ingredient one or more aluminum compounds.

Abstract: Dermatological compositions comprising nitrous oxide and at least one essential fatty acid or lower alkyl ester thereof in a dermatologically acceptable carrier medium is useful in the treatment of a variety of skin, muscle and joint disorders including psoriasis, shingles, fever blisters, chicken pox, ache, chilblains, eczema, chloasmas, alopecia, dermatitis, ringworm and burn wounds. The composition preferably also includes additional ingredients selected from coal tar, collagen, nicotinamide, nicotinic acid, lanolin, vitamin E, methyl salicylate, arnica, and H.sub.1 -antagonist antihistamines or combinations thereof.

Abstract: The invention provides a composition for treating seborrheic dermatitis on the scalp, a method for treating seborrheic dermatitis and a method for making the composition of the invention. The composition of the invention, which is not a shampoo and does not contain any soap or detergent for cleaning hair, is a unique scalp medicament blend of ingredients. The composition comprises from about 0.5 to about 2.5 weight percent, based upon the weight of the composition, hydrocortisone; from about 2.5 to about 7.5 weight percent elemental sulfur; and from about 90 to about 97 weight percent of an active vehicle comprising a generally neutral hydrocarbon jelly, such as petrolatum or petroleum jelly, and gelled aqueous carboxypolymethylene.

Abstract: Provided is a anti-dandruff shampoo composition comprising: (a) from about 8% to about 40%, by weight, of anionic detersive surfactant; (b) from about 0.1% to about 5%, by weight, of particulate anti-dandruff agent having an average particle size of from about 0.35 microns to about 5 microns; (c) from about 0.01% to about 1.0%, by weight, of a stabilizing agent for said anti-dandruff agent, said stabilizing agent being a soluble cationic polymer; (d)from about 50% to about 91.89%, by weight, water; wherein said shampoo composition is substantially free of suspending agents selected from the group consisting of crystalline suspending agents and anionic, nonionic, and amphoteric polymeric suspending agents. Also provided is a process used for making the present compositions wherein said particulate anti-dandruff agent and said cationic polymer are admixed in water in the presence of anionic detersive surfactant.

Abstract: The present invention relates to methods for detecting the effects of selected growth factors and pharmaceuticals on the growth and development of hair follicles by assaying hair follicle cell proliferation and cellular collagenolytic factor secretion. In particular, isolated hair follicle cells maintained as intact functioning folliculoids are embedded in a three-dimensional culture system, and exposed to the chemical agent of choice. The effect of this agent can then be determined with respect to its ability to modify cellular proliferation or secretion of proteolytic factors. Each determination involves the use of a separate assay.

Abstract: A method of treatment for androgenic alopecia is disclosed wherein Liquor Carbonis Detergens is topically administered.

Abstract: The invention relates to a cosmetic or pharmaceutical composition which comprises oxyacanthine, one of its derivatives, one of their cosmetically or pharmaceutically acceptable acid addition salts or an extract of a plant in which it is present, such as Berberis vulgaris or barberry. One particular association is that of oxyacanthine with a saponin. This composition can be intended in particular for stimulating hair growth, retarding hair loss or combating pruritus.

Abstract: A method is provided for treating hair with an active ingredient such as an anti-dandruff and/or sunscreen agent by delivery within a cationic liposomal dispersion. The dispersion is pre-prepared with inclusion of the active ingredient, and then incorporated into the final hair treatment composition.

Abstract: Compositions of gel-like appearance, comprising an oily phase formed of at least 75% of organopolysiloxane, dispersed in an aqueous phase containing at least 25% of water, using an emulsifying agent formed of at least one sucrose ester, are stable in the presence of compounds which are not compatible with conventional gelling agents.

Abstract: This application proposes a new topical treatment for the stimulation and induction of hair growth as well as for preventing further hair loss. These pharmacologic results would be achieved by stimulation of an inactive hair follicle or by reversing the dysfunction of the hair follicles or by improvement of the general physiologic state of the scalp skin. It would also stimulate the maturation and differentiation of those cells specifically involved in hair growth either directly or by stimulating the organelles and supporting structures associated with the hair follicle. The topical composition comprises vitamin D.sub.3 or various nitro-benzoic acids esters thereof, or the biologically active metabolites of vitamin D.sub.3 preferabiy affixed, during preparation to microparticulate charged non-metaliic microparticles and aloe. The final concentration of vitamin D.sub.3 in the composition is 0.5% or 500,000 IU by volume.

Abstract: Certain combinations of lactate dehydrogenase inhibitors and specific carboxylic acids stimulate keratinocyte proliferation and collagen synthesis in skin.

Abstract: A hair shampoo composition comprising a cleansing surfactant; a water-insoluble hair treating compound, like a hair conditioner or an antidandruff agent; a suspending agent comprising an amine including at least one long carbon chain and a suitable acid; and a suitable carrier, and a method of treating hair are disclosed. The shampoo compositions effectively suspend the water-insoluble hair-treating compound, effectively cleanse the hair and effectively deliver the water-insoluble hair-treating compound to the hair or scalp.

Abstract: A composition for enhancing hair growth which comprises a compound represented by the following formula (I) as an active ingredient: ##STR1## wherein R.sup.1 represents an alkyl group having 1 to 8 carbon atoms, R.sup.2 represents an alkyl group having 1 to 10 carbon atoms, an alkenyl group having 2 to 6 carbon atoms or a cycloalkyl group having 3 to 8 carbon atoms and X represents --O-- or --NH-- and a carrier or diluent acceptable for topical composition.The composition for enhancing hair growth of the present invention has a hair growth enhancing activity and therefore is useful as a hair growth preparation.

Abstract: Prostaglandins of the PGE type can be administered in a therapeutically effective amount to protect tissue from injury resulting from chemotherapeutic agents by administering the PGE-type prostaglandin prior to administration of the chemotherapeutic agent.